Views & Analysis | Perspectives on pharma industry issues

R&D

Inspection readiness is now a commercial question

Manufacturers of advanced therapies are discovering that a digital quality system does more than satisfy inspectors.

Digital

Abstract AI concept, turquoise hexagonals on dark background

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

Articles

Emerging markets – the new gold rush? (part 1)

Amit Vaidya offers a guide to considerations and risks associated with entering emerging markets in the first of this three part series. The Pharmaceutical industry in common with many other sectors goes through what one might describe metaphorically as “fashionable change”. Examples might be...

Articles

Four reasons the iPad is a sales rep's best friend

As use of iPads continues to increase Maureen Shaffer flags the four reasons that suggest that the iPad is the sales rep’s best friend. iPads are vaulting ahead in pharmaceutical and medical device companies. The WSJ Health Blog recently noted that it was becoming an...

Articles

Editor’s voice – June 2011

Continuing her monthly editor’s blog, Rebecca Aris discusses some recent highlights and shows us what’s in store on pharmaphorum over the next few weeks. It’s time again for another roundup of the past month’s editorial activities. Despite the distinct lack of sunshine here in the UK...

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.